Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study - Université de Rennes Access content directly
Journal Articles Haematologica Year : 2020

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study

Fichier principal
Vignette du fichier
Morschhauser et al-2020-Clinical activity of abemaciclib in patients with relapsed or refractory mantle.pdf (1.16 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02635130 , version 1 (29-05-2020)

Identifiers

Cite

Franck Morschhauser, Kamal Bouabdallah, Stephan Stilgenbauer, Catherine Thieblemont, Sophie de Guibert, et al.. Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study. Haematologica, 2020, ⟨10.3324/haematol.2019.224535⟩. ⟨hal-02635130⟩

Collections

UNIV-RENNES
50 View
188 Download

Altmetric

Share

Gmail Facebook X LinkedIn More